Loncar Cancer Immunotherapy Etf Technical Analysis

CNCR Etf  USD 14.19  0.37  2.68%   
As of the 28th of November, Loncar Cancer secures the Risk Adjusted Performance of (0.04), standard deviation of 2.12, and Mean Deviation of 1.61. Loncar Cancer Immunotherapy technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the etf's future prices. Please verify Loncar Cancer Immuno variance and potential upside to decide if Loncar Cancer Immunotherapy is priced some-what accurately, providing market reflects its recent price of 14.19 per share.

Loncar Cancer Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Loncar, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Loncar
  
Loncar Cancer's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Loncar Cancer technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
A focus of Loncar Cancer technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Loncar Cancer trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Loncar Cancer Immuno Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Loncar Cancer Immuno volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Loncar Cancer Immuno Trend Analysis

Use this graph to draw trend lines for Loncar Cancer Immunotherapy. You can use it to identify possible trend reversals for Loncar Cancer as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Loncar Cancer price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Loncar Cancer Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Loncar Cancer Immunotherapy applied against its price change over selected period. The best fit line has a slop of   0.02  , which may suggest that Loncar Cancer Immunotherapy market price will keep on failing further. It has 122 observation points and a regression sum of squares at 12.64, which is the sum of squared deviations for the predicted Loncar Cancer price change compared to its average price change.

About Loncar Cancer Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Loncar Cancer Immunotherapy on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Loncar Cancer Immunotherapy based on its technical analysis. In general, a bottom-up approach, as applied to this etf, focuses on Loncar Cancer Immuno price pattern first instead of the macroeconomic environment surrounding Loncar Cancer Immuno. By analyzing Loncar Cancer's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Loncar Cancer's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Loncar Cancer specific price patterns or momentum indicators. Please read more on our technical analysis page.

Loncar Cancer November 28, 2024 Technical Indicators

Most technical analysis of Loncar help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Loncar from various momentum indicators to cycle indicators. When you analyze Loncar charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Loncar Cancer Immuno One Year Return

Based on the recorded statements, Loncar Cancer Immunotherapy has an One Year Return of 30.2%. This is 238.34% lower than that of the Loncar Investments family and 238.34% lower than that of the Health category. The one year return for all United States etfs is notably lower than that of the firm.
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.

Loncar Cancer November 28, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Loncar stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Loncar Cancer Immuno is a strong investment it is important to analyze Loncar Cancer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Loncar Cancer's future performance. For an informed investment choice regarding Loncar Etf, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Loncar Cancer Immunotherapy. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
The market value of Loncar Cancer Immuno is measured differently than its book value, which is the value of Loncar that is recorded on the company's balance sheet. Investors also form their own opinion of Loncar Cancer's value that differs from its market value or its book value, called intrinsic value, which is Loncar Cancer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Loncar Cancer's market value can be influenced by many factors that don't directly affect Loncar Cancer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Loncar Cancer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Loncar Cancer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Loncar Cancer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.